An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.

Gore M, Hackshaw A, Brady WE, Penson RT, Zaino R, McCluggage WG, Ganesan R, Wilkinson N, Perren T, Montes A, Summers J, Lord R, Dark G, Rustin G, Mackean M, Reed N, Kehoe S, Frumovitz M, Christensen H, Feeney A, Ledermann J, Gershenson DM

Open source

DOI: 10.1016/j.ygyno.2019.03.256
Published: 2019 Jun
Container: Gynecologic oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2019.03.256,
  title = {An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.},
  author = {Gore M and Hackshaw A and Brady WE and Penson RT and Zaino R and McCluggage WG and Ganesan R and Wilkinson N and Perren T and Montes A and Summers J and Lord R and Dark G and Rustin G and Mackean M and Reed N and Kehoe S and Frumovitz M and Christensen H and Feeney A and Ledermann J and Gershenson DM},
  year = {2019},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2019.03.256},
  url = {https://doi.org/10.1016/j.ygyno.2019.03.256}
}

RIS

TY  - JOUR
TI  - An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
AU  - Gore M
AU  - Hackshaw A
AU  - Brady WE
AU  - Penson RT
AU  - Zaino R
AU  - McCluggage WG
AU  - Ganesan R
AU  - Wilkinson N
AU  - Perren T
AU  - Montes A
AU  - Summers J
AU  - Lord R
AU  - Dark G
AU  - Rustin G
AU  - Mackean M
AU  - Reed N
AU  - Kehoe S
AU  - Frumovitz M
AU  - Christensen H
AU  - Feeney A
AU  - Ledermann J
AU  - Gershenson DM
PY  - 2019
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2019.03.256
UR  - https://doi.org/10.1016/j.ygyno.2019.03.256
ER  -

APA

M, G., A, H., WE, B., RT, P., R, Z., WG, M., R, G., N, W., T, P., A, M., J, S., R, L., G, D., G, R., M, M., N, R., S, K., M, F., H, C., A, F., J, L., & DM, G. (2019). An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2019.03.256

Source records

pubmed · retrieved 2026-09-26T12:10:26.554Z